Welcome to our dedicated page for Cabot SEC filings (Ticker: CBT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Cabot Corporation (NYSE: CBT) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures filed with the U.S. Securities and Exchange Commission. As a global specialty chemicals and performance materials company, Cabot uses its SEC filings to report financial performance, segment results for Reinforcement Materials and Performance Chemicals, risk factors, sustainability information and corporate governance matters.
Investors can review Cabot’s annual reports on Form 10-K and quarterly reports on Form 10-Q to see detailed discussions of net sales, earnings, segment EBIT, regional volume trends and cash flows, along with commentary on demand conditions in the Americas, Europe, the Middle East and Africa, and Asia Pacific. These filings also describe key product areas such as reinforcing carbons, specialty carbons, battery materials, fumed metal oxides, inkjet colorants, masterbatches and conductive compounds, engineered elastomer composites and aerogel.
Cabot’s current reports on Form 8-K disclose material events, including the release of quarterly operating results, agreements such as the planned acquisition of Mexico Carbon Manufacturing S.A. de C.V. from Bridgestone Corporation, supply arrangements for battery materials and changes in board composition. Form 8-K filings also reference earnings press releases that provide non-GAAP measures like Adjusted EPS, Total Segment EBIT and Adjusted EBITDA, along with reconciliations to GAAP metrics.
Through Stock Titan, users can track Cabot’s real-time filing activity from EDGAR and use AI-powered summaries to interpret complex documents. These summaries highlight key points from lengthy 10-K and 10-Q filings, explain the significance of non-GAAP measures and clarify disclosures about segment performance, sustainability initiatives and capital allocation. The filings page also helps users locate proxy materials and insider transaction reports on Form 4, which provide additional context on executive and director roles, equity-based compensation and share ownership changes.
By consolidating Cabot’s SEC filings with AI-generated insights, this page supports users who want to understand how the company reports on its reinforcing carbons and performance chemicals businesses, evaluates risks and opportunities, and communicates with regulators and investors.
Cabot Corporation (CBT)
Cabot Corporation (CBT) senior vice president and general counsel Karen A. Kalita reported equity awards and related share activity on a Form 4 dated for transactions on 11/19/2025.
She acquired 4,518 shares of common stock at a stated price of $0, increasing her direct holdings. She also acquired 4,084 common shares at a stated price of $0, described as performance-based units earned for fiscal 2025, with 2,931 of those still subject to time-based vesting. To cover obligations associated with these awards, 872 shares were disposed of at $59.76 per share.
Following these transactions, she directly held 45,242 common shares and indirectly held 577.005 shares through the trustee for the corporation’s 401(k) plan. In addition, she was granted an employee stock option for 16,908 shares of common stock with an exercise price of $59.76 per share, expiring on 11/18/2035, vesting 30% on 11/19/2026, 30% on 11/19/2027, and 40% on 11/19/2028.
Cabot Corporation (CBT) officer Lisa M. Dumont, VP, Controller & CAO, reported equity transactions in company stock on a Form 4 dated 11/19/2025. She acquired 1,606 shares of common stock at $0 and an additional 901 performance-based units at $0, reflecting awards tied to the corporation's fiscal 2025 performance, of which 637 units remain subject to time-based vesting. She also disposed of 200 shares of common stock at $59.76 in a transaction coded as tax withholding (code F). After these transactions, she directly beneficially owned 11,715 shares of Cabot common stock and indirectly held 1,598.5907 shares through the trustee for the corporation's 401(k) plan.
Cabot Corporation reported insider equity activity for its Executive Vice President and CFO, Erica McLaughlin, on a Form 4. On 11/19/2025, she acquired 8,283 shares of Cabot common stock at
The disclosure also records a grant of an employee stock option for 30,998 shares of common stock with an exercise price of
Cabot Corporation executive Jeff Ji Zhu reported new equity awards and share movements in company stock. On November 19, 2025, he acquired 6,024 shares of Cabot common stock at $0 per share, and an additional 5,445 performance-based units that converted into common stock at $0. After these transactions, he directly owned 85,337 common shares.
The filing also shows a disposition of 998 common shares at a price of $59.76 per share on the same date. In addition, Zhu received an employee stock option giving him the right to buy 22,544 shares of Cabot common stock at an exercise price of $59.76 per share, expiring on November 18, 2035. These options vest over three years: 30% on November 19, 2026, 30% on November 19, 2027, and 40% on November 19, 2028.
Cabot Corporation President and CEO Sean D. Keohane, who is also a director, reported multiple equity awards dated 11/19/2025. He received 32,630 shares of common stock and an additional 30,932 performance-based units earned on fiscal 2025 results, with 22,630 of those units still subject to time-based vesting.
To cover obligations tied to these awards, 10,338 shares were disposed of at $59.76 per share. After these transactions, Keohane beneficially owned 404,134 Cabot common shares directly and 13,933.1846 shares indirectly through the company’s 401(k) plan. He was also granted an employee stock option for 122,114 shares at an exercise price of $59.76, vesting 30% on November 19, 2026, 30% on November 19, 2027 and 40% on November 19, 2028, expiring on November 18, 2035.
Cabot Corporation (CBT) reported an insider transaction on a Form 4 for President & CEO and Director Sean D. Keohane. On 11/11/2025, a transaction coded F reflected the disposition of 10,608 shares at $61.41 per share. Following this activity, he beneficially owns 350,910 shares directly. He also holds 13,933.18 shares indirectly through the trustee for the corporation’s 401(k) plan.
Cabot Corporation (CBT) executive vice president and CFO Erica McLaughlin filed a Form 4 reporting a Code F transaction on 11/11/2025. The filing shows the disposition of 2,253 shares of common stock at $61.41 per share.
Following the transaction, she beneficially owned 64,815 shares directly. The filing also lists 1.6507 shares held indirectly through the trustee for the company’s 401(k) plan.
Cabot Corporation (CBT) disclosed a Form 4 for SVP and General Counsel Karen A. Kalita reporting a transaction on 11/11/2025. The filing lists a Transaction Code F involving 895 shares of common stock at $61.41.
Following the reported transaction, Kalita beneficially owns 37,512 shares directly and 577.0049 shares indirectly through the trustee for the corporation's 401(k) plan.
Cabot Corporation (CBT) executive Jeff (Ji) Zhu filed a Form 4 reporting an insider transaction. On 11/11/2025, a transaction coded F involved 1,024 shares of Cabot common stock at $61.41 per share.
After the transaction, he directly beneficially owned 74,866 shares. The filing identifies him as an Executive Vice President and indicates direct (D) ownership.
FAQ
What is the current stock price of Cabot (CBT)?
What is the market cap of Cabot (CBT)?
